Home/Crestone/Thale Jarvis, Ph.D.

TJ

Thale Jarvis, Ph.D.

Co-Founder, Science Advisor, former CSO

Therapeutic Areas

Infectious Disease Antimicrobial Resistance

Crestone Pipeline

Drug	Indication	Phase
CRS3123	Clostridioides difficile infection (CDI)	Phase 2
Undisclosed Program	Antibiotic-resistant Gram-positive infections (e.g., MRSA, VRE)	Preclinical

Leadership Team at Crestone

Nebojsa Janjic, Ph.D.

Co-Founder, CEO and President

Urs Ochsner, Ph.D.

Co-Founder, COO and VP, R&D

John Rohloff, Ph.D.

Co-Founder, Senior Chemistry Advisor

Jon Bruss, M.D., M.B.A.

Acting Chief Medical Officer

View full Crestone profile